|
Yan-Yan
Yu, Chong-Wen Si, Xiu-Lan Tian, Qun He, Hai-Peng Xue, 1Department
of Infectious Diseases, 2Department of Pathology, The
First Teaching Hospital, Beijing Medical University,
Beijing 100034, China
Dr. Yan-Yan
Yu,
female, born on 1962-12-14 in Lanzhou City, Gansu Province, China,
graduated from Beijing Medical University as a Ph.D. in 1994, now
associate professor of infectious diseases majoring infectious
diseases, having two papers published.
Supported by National Natural Science Foundation of China,
No.39170704.
Correspondence to: Dr. Yan-Yan
Yu,
Department of Infectious Diseases, The First Teaching Hospital,
Beijing Medical University, Beijing 100034, China
Telephone:
+86-10-66171122 ext 2362,
Fax.
+86-10-66176450
Received: 1998-05-18
Subject
headings: hepatitis; liver necrosis;
tumor necrosis factor; interleukins; interferon
Yu YY, Si CW, Tian XL, He Q, Xue HP.Effect of cytokines on liver
necrosis.World J Gastroenterol, 1998;4(4):311-313
Abstract
AIM: To investigate the effect of cytokines on the liver
necrosis.
METHODS: rIL (interleukin)-1, rIL-6, rIFN (interferon), rTNF
(tumor necrosis factor) α with or without D-galactosamine
(D-GAL) were injected into the abdominal cavity of mice separately.
ALT, TBIL (total bilirubin) and histological changes were observed.
RESULTS: There was no effect on hepatocyte of normal mice
after injection of rIL-1, rIL-6, rIFN alone or together. The serum
total bilirubin (TBIL) and liver necrosis of mice increased after
rTNFα, rIL-6 or rIFN were used separately with D-GAL. The TBIL
level (μmol/L)was 46.19±10.62, 44.55±12.9 and 41.94±14.9,
higher than that caused by D-GAL alone (TBIL, 26.67μmol/L±11.14μmol/L).
The serum TBIL of mice and the degree of liver necrosis increased
after injection of IL-1, IL-6 with D-GAL and rTNFα.
CONCLUSION: Cytokines, like IL-1, IL-6, IFNγ and TNFαjoined
in the process of hepatocyte necrosis.They can enhance the degree of
liver necrosis induced by D-GAL.
INTRODUCTION
Immune system in human body is a net system and so are the effects
of cytokines, which can be affected by other cytokines. They promote
or inhibit each other, TNFα can aggravate hepatic necrosis[1],
and its effect is also influenced by other cytokines. The levels of
IL-1, IL-6 and IFN in plasma of hepatitis patients were increased
after infection[2-6].
We investigated the effect of multicytokines to understand the
synergistic action of multicytokines.
MATERIALS AND METHODS
Material and animal
Animal Ninety-six Balb/c male mice weighing 20g each were
used. They were provided by the Center of Experiment Animal of
Chinese Academy of Medical Sciences.
Reagent rIL-1 (105U/ml), rIL-6 (105u/ml),rIFN
(5×105U/ml) andrTNFα (5×105U/ml) were
provided by the Chinese Academy of Military Medical Sciences. D-GAL
were derived from Department of Chemistry, Chongqing Medical
University.
Method
The effect of rIL-1, rIL-6, rTNFα and rIFN on normal mice
Thirty mice were selected and divided into 5 groups. rIL-1 (10 6U/kg),
rIL-6 (106U/kg), rIFN (5×106U/kg) andrTNFα
(5×105U/kg) were injected into the abdominal cavity of
mice separately and normal saline was used for the control. TBIL and
ALT were detected 48 hours after the injection. The pathologic
changes of the liver were observed.
The combined effect of TNFα with IL-1 or IL-6 or IFN on
liver Eighteen mice were selected and divided into 3 groups.
TBIL and ALT were detected 48 hours after injection ofrTNFα
with rIL-1, or rIL-6, orrIFN-separately into the abdominal cavity.
Liver histological changes were observed at the same time.
The aggravating effect of rIL-1, rIL-6, rIFN and rTNFα
separately in liver necrosis Thirty mice were divided into 5
groups. D-GAL (1.5g/kg), or D-GAL with rIL-1 (5×104U/kg)
or rIL-6 (5×104U/kg) or rIFN (2.5×105U/kg)
or rTNFα (1×104U/kg) were injected separately into
abdominal cavity of mice. Serum TBIL and pathologic changes in liver
were compared with the control after 48 hours.The rest 18 mice were
divided into 3 groups. D-GAL and rTNFα with rIL-1 or rIL-6 or
rIFN (the same dose as above) were injected into the abdominal
cavity of mice separately.
ALT and TBIL detection Beckman Biochemistry Machine was used to
detect the serum ALT and TBIL. Methods of liver biopsy[7]
Hepatic
tissues were taken and fixed in Bovin′s
fluid. After dehydration they were embedded in paraffin wax, and
sections were made, and stained by HE. We marked mild degeneration
as -
or ±, spot necrosis as +, small
piece necrosis as ++ , sublarge necrosis as +++ , large necrosis as
++++.
Statistical analysis χ2 test was used to
compare the difference among groups.
RESULTS
The effect of multicytokines on normal liver of mice
rTNFα, rIL-1, rIL-6 and rIFN were injected into the abdominal
cavity of normal mice separately. The changes of their hepatic
function are shown in Table 1 . And the results of their hepatic
histologic examination were -
or ±. There was no difference
from normal control. There was no difference in TBIL and ALT either
between each group, indicating that the injection of rTNFα,
rIL-1, rIL-6 and rIFN have no effects on liver function and liver
histology of normal mice.
Table 1 The changes of liver function after cytokines
injection in mice (mean±SD
)
|
|
n
|
TBIL(μmol/L)
|
ALT(IU/L)
|
AST(IU/L)
|
|
Control
|
6
|
7.28±4.82
|
46±4
|
187±28
|
|
rTNFα
|
3
|
8.70±5.34
|
50±11
|
89±27
|
|
rIL-1
|
3
|
7.23±0.87
|
40±5
|
76±10
|
|
rIL-6
|
3
|
11.77±3.51
|
31±1
|
62±2
|
|
rIFN-γ
|
3
|
9.30±2.7
|
31±5
|
89±13
|
F=08
between groups, P>0.05
The effect of rTNFα with rIL-1 or rIL-6 or rIFN on normal
mice rTNFα with rIL-1, or rIL-6, or rIFNγ
were injected into the abdominal cavity of normal
mice. The changes of their liver function are shown in Table 2 .
There was no difference in TBIL and ALT among the groups, and no
difference in liver histology compared with normal control. So, it
is obvious that rTNFα with rIL-1 or rIL-6 or rIFNγ
had no effect on liver function and liver
histology of normal mice.
Table 2 The combined effect of rTNFα with rIL-1 or rIL-6
or rIFNγ
on liver function of normal mice (mean±SD)
|
|
n
|
TBIL(μmol/L)
|
ALT(IU/L)
|
AST(IU/L)
|
|
Control
|
6
|
7.28±4.82
|
46±4
|
187±28
|
|
rTNFα
|
3
|
8.70±5.34
|
50±11
|
89±27
|
|
rTNFα+rIFNγ
|
3
|
7.38±6.01
|
32±3
|
100±14
|
|
rTNFα+rIL-1
|
3
|
8.59±5.9
|
42±11
|
128±19
|
|
rTNFα+rIL-6
|
3
|
10.85±3.25
|
36±5
|
115±12
|
F=0.8,
between groups, P>0.05.
The
effect of cytokines on mice liver
DGal combined with cytokines were injected separately into the
abdominal cavity of mice. The results of liver function and hepatic
histology are shown in Table 3. The level of TBIL in different
groups of cytokine was higher than that of controls. The TBIL level
in groups of D+rIL-6,D+rIFN and D+rTNFα rose significantly
compared with group D, and hepatic necrosis worsened. There was no
difference in TBIL level between group D+rIL-1 and group D.
Table 3 The effect of D-GAL with cytokines on TBIL and
histological changes of liver
|
Group
|
n
|
TBIL(μmol/L)
|
Histological
changes (n)
|
|
±
|
+
|
++
|
|
Control
|
6
|
7.28±4.82
|
6
|
|
|
|
D-GAL
|
6
|
26.67±11.14
|
|
6
|
|
|
D+rIL-1
|
6
|
29.69±9.6
|
|
6
|
|
|
D+rIL-6
|
6
|
45.55±12.9a
|
|
1
|
5
|
|
D+rIFNγ
|
6
|
41.94±14.9a
|
|
2
|
4
|
|
D+rTNFα
|
6
|
46.19±10.62a
|
|
2
|
4
|
aP<0.05,
vs group D GAL.
Table 4 The effects of DGal and rTNFα with rIL-1, rIL-6,
rIFN- separately on TBIL and hepatic cell of mice
|
Group
|
n
|
BIL(μmol/L)
(mean±SD)
|
Histological
changes
|
|
-or±
|
+
|
++
|
+++
|
++++
|
|
Control
|
6
|
7.28±4.8
|
6
|
|
|
|
|
|
D+rTNFα
|
6
|
46.19±10.6
|
|
2
|
4
|
|
|
|
D+rTNFα+rIL-1
|
6
|
66.27±18.7a
|
|
|
|
3
|
3a
|
|
D+rTNFα+rIL-6
|
6
|
69.28+18.9a
|
|
|
|
2
|
4a
|
|
D+rTNFα+rIFNγ
|
6
|
36.75±14.5
|
|
2
|
4
|
|
|
a
P<0.05,
vs group of D+rTNFα.DGal and rTNFα with rIL-1, or rIL-6 or
rIFNγ
were injected into the abdominal cavity of mice. The results of
liver function and hepatic histology are shown in Table 4 . The
degree of hepatic necrosis was more severe and the level of TBIL was
higher in group D+T+1 and group D+T+6 than in group D+T. There was
no significant difference between group D+T+IFNand group D+T. It is
suggested that D+T can raise the level of TBIL and the degree of
hepatic necrosis. And adding, rIL-1 and rIL-6 can increase the level
of TBIL and ALT and enhance the degree of liver necrosis, but no
difference with rIFNγ.
DISCUSSION
Our experimental results showed that various cytokines, such as TNFα,
IL-1, IL-6 and rIFN alone or together have no effect on liver. But
TNFα, rIL-6 and rIFNγ
can enhance the degree of liver lesions caused by D-Gal and rIL-1
and rIL-6 can aggravate liver necrosis caused by TNFα.
Lipopolysaccharide
(LPS) is a very strong inducer of many cytokines. It can induce
IL-1, IL-6,TNFα and IFN and so on, [8,9]
e.g., hepatitis B can induce TNFα
in hepatocytes[10].
Besides increased TNFα in patients with viral hepatitis, the
level of many other cytokines was elevated, for example IL-1, IL-6
and IFN. The effect of any cytokine could be affected by other
cytokines. IFN can induce the production of TNFα[11],
which produced cytokines including IL-1 and IL-6. So, not only TNFα,
but many other cytokines affect the liver function when infections
appear. Our results demonstrated the role of multiple cytokines in
hepatic necrosis. There might be many routes for multiple cytokines
to worsen the hepatic damage in hepatitis. One of the routes is
local Shwartzman reaction. TNFα and LPS can induce Shwartzman
as either sensitizing agent or stimulating agent[12].
TNFα together with IL-1, IL-6 can aggravate hepatic necrosis
and bleeding. They can spoil the cell membrane by inducing
indirectly serine protease and by activating phosphatase A2[13].
Cytokines could not induce hepatic lesions in mice with normal liver
function. The susceptibility to cytokines was increased after
injection of D-GAL. D-GAL, actimycin D and mitomycin C are
hepatocyte-specific inhibitors of RNA synthesis. The toxic effect of
cytokine can increase dramatically when cytokines injected with DGAL[14].
The catabolism and anabolism of protein in hepatocytes are affected
in hepatopathy and the toxic effect of cytokine can reveal in
hepatitis.
It
can be supposed that viral infection and bacteriotoxemia in patients
with hepatitis can induce a large amount of cytokines and aggravate
liver necrosis through their interaction, resulting in severe
hepatitis. To study the effect of multicytokines in patients with
hepatitis is of great importance to understand the mechanism of
hepatic necrosis and to search for effective means for prevention
and treatment of liver necrosis.
REFERENCES
1 Yu YY, Si CW, Lang ZW, Tian XL, He Q, Xue HP.
The effect of tumor necrosis factor on viral hepatitis.Chin J Intern
Med,
1996;(35)1:28-31
2 Anastassakos C, Alexander GTM, Worstencroft
RA.Interleukin-1 and interleukin-2 activity in chronic hepatitis B
virus
infection. Gastroenterology,
1988;94(4):999-1005
3 Shinichi Kakumu,Tadashi Shinagawa, Tetsuya
Ishikawa. Serum Interleukin 6 level in patients with chronic
hepatitis B.
Am J Gastroenterol,
1991;86(12):1804-1808
4 Khoruts A, Stahnke L, Mcclain CJ, Logan G, Allen
JH. Circulating tumor necrosis factor, interleukin-1 and
interleukin-6 concentrations in
chronic alcoholics. Hepatology,1991;13(2):267-276
5 Mcclain CJ, Hill DB and Schmid J. Cytokines and
alcoholic liver diseases. Semin Liver Dis, 1993;13(1):170-182
6 Yeqing S, Katsutoshi T, Etsuko I, Katsumi Y,
Hiroshi O. Elevated serum interleukin-6 level in patients with acute
hepatitis.
J Clin Immun, 1992;12(3):197-200
7 Huang F, Wang JY, Gao H, Dong XJ. The level of
tumor necrosis factor in plasma of mice and the protection effect of
HCG
and PGE. J Chin Med
Univ,1993,22(4):275-277
8 Blanchard DK, Djeu JY, Klein TW, Priedmen H,
Stewart WE. Interferon induction by Lipopolysaccharide, dependence
on interleukin 1 and macrophage. J
Immunol,1986;136(3):963-976
9 Lehmann V, Freudenberg MA, Galanos C. Lethal
toxicity of LPS and TNF in normal and D-GAL treated mice. J Exp Med,
1987;165(3):657-663
10 Gozalez AR, Garcia MC, Garcia BL, Moreno OR, Alonso JL,
Yaque E. Induction of tumor necrosis fector α production by
human
hepatocytes in chronic viral hepatitis.J Exp Med,
1994;179(3):841-848
11 Marshall JS, Dolovich J, and Waserman S. The induction of
peripheral blood mononuclear cell TNFα production by IFN can
be
inhibited by budedonide. J Aller Clin Immunol,1995;95(2):365
12 Bian ZQ, Wang WY, Qin YZ, Qin RM, Wang GZ, Qin HY.
Experimented study of Tumor-Necrosis Factor induced acute
liver
necrosis in Duckling infected with DHBV.J Chin Infect
Dis,1992,10(2):88-92
13 Suffys P, Beyaert R, Vanvoy F and Fiers W. Involvement of a
serine protease in tumor-necrosis factor mediated
cytotoxicity. Eur
J Biochem,1988;178(1):257-265
14 Alcorn JM, Fierer J, Chojkier M. The acute phase response
protects mice from D-GAL sensitization to endotoxin and
tumor
necrosis factor-α.Hepatology, 1992;15(1):122-129
| |